Nouvelles
Découvrez les dernières nouvelles et les développements en IA et en apprentissage automatique dans le domaine de la thérapie guidée par imagerie (TGI) au Canada.
Du risque à l’hyperprécision : Comment ViTAA Medical tire profit de l’imagerie et de l’IA pour redéfinir le traitement de l’anévrisme aortique
Using AI-assisted 3D modelling, ViTAA Medical is determined to bring aneurysm management into the 21st century. For the last 15 years, Dr. Elena Di Martino, a biomedical engineer and Dr. Randy Moore, a vascular surgeon (both teach at the University of Calgary), have been perfecting technology that uses computer algorithms to analyze information gathered on a CT scan to create 3D models of aneurysms that encode the actual mechanical properties of the vessel’s wall.
Comment 16 Bit a mis à profit l’IA pour prévenir les fractures coûteuses, une radiographie à la fois
As with many transformative businesses, 16 Bit came to be because of, sure, the brilliance and vision of its founders, but also a great deal of serendipity. 16 Bit might not exist had Dr. Mark Cicero and Dr. Alexander Bilbily not both chosen to pursue medical school (with backgrounds in engineering and computer science, respectively), had they not both decided to specialize in radiology, and had they not ended up in the same residency training program at the University of Toronto.
INOVAIT reveals Canada’s strategic advantages in image-guided therapy and artificial intelligence in latest report
INOVAIT, the pan-Canadian innovation network supporting advancements and commercialization in image-guided therapy (IGT) and artificial intelligence (AI), is excited to share their latest report titled, ‘Unlocking Medtech’s Potential: Canada’s Strategic Advantages in Image-Guided Therapy & AI’. Through synthesized insights from interviews with founders and executives from 30 IGT companies in the INOVAIT Network, this new report uncovers the untapped potential of the image-guided therapy sector in Canada.
Nouvelles du réseau
Sonic Incytes is making liver screening more accessible
Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).
Le fonds Pilote d’INOVAIT accepte maintenant les candidatures pour des projets de thérapie guidée par imagerie
October 18, 2023 | Toronto, ON – INOVAIT, the pan-Canadian network for image-guided therapy (IGT), is now accepting...
Travailler dans le secteur IGT au Canada : les entreprises IGT embauchent dès maintenant
Les entreprises membres d'INOVAIT recherchent des talents qui pourraient contribuer à transformer la prestation des soins de santé. Serait-ce vous ?...
Le programme de bourses en technologie médicale, créé par Sunnybrook à Toronto, lance un deuxième programme avec le Centre d’innovation en santé de la Nouvelle-Écosse
Medventions, établie par Sunnybrook à Toronto, lance un deuxième programme avec le Nova Scotia Health Innovation Hub
Série de conférences sur la TGI
Regulating AI in Image-Guided Therapy
Suivre INOVAIT sur les médias sociaux
Le Réseau dans la presse
